Showing results (21-30 of 5,448) with videos related to
Sort By:
Pageof 545
Cell Cycle (Georgetown, Tex.)|December 15, 2015
RAS-MAPK in ALK targeted therapy resistanceGorjan Hrustanovic, Trever G BivonaCancer Cell|June 25, 2021
Stepwise evolution of therapy resistance in AMLPhilippe Gui, Trever G BivonaMolecular & Cellular Oncology|June 17, 2016
RAS-MAPK signaling influences the efficacy of ALK-targeting agents in lung cancerGorjan Hrustanovic, Trever G BivonaSmall Gtpases|February 23, 2016
RAS signaling in ALK fusion lung cancerGorjan Hrustanovic, Trever G BivonaThe Journal of Clinical Investigation|February 15, 2022
Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancerTadashi Manabe, Trever G BivonaCaring : National Association for Home Care Magazine|November 4, 1992
The nutrition screening initiativeM F Tonore, B BivonaOncogene|February 24, 2015
Adaptive stress signaling in targeted cancer therapy resistanceE Pazarentzos, T G BivonaTrends in Cancer|March 23, 2019
Polytherapy and Targeted Cancer Drug ResistanceNilanjana Chatterjee, Trever G BivonaTrends in Cancer|December 7, 2021
Evolution of metastasis: new tools and insightsPhilippe Gui, Trever G BivonaChemotherapy Research and Practice|September 13, 2012
Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC PatientsLuping Lin, Trever G BivonaPageof 545